Exceptional Response to Systemic Therapy in Advanced Metastatic Gastric Cancer: A Case Report. (Record no. 4122)

MARC details
000 -LEADER
fixed length control field 01902nam a22003377a 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 190314s20162016 xxu||||| |||| 00| 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2168-8184
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code 10.7759/cureus.457 [doi]
024 ## - OTHER STANDARD IDENTIFIER
Standard number or code PMC4752374 [pmc]
040 ## - CATALOGING SOURCE
Original cataloging agency Ovid MEDLINE(R)
099 ## - LOCAL FREE-TEXT CALL NUMBER (OCLC)
PMID 26918225
245 ## - TITLE STATEMENT
Title Exceptional Response to Systemic Therapy in Advanced Metastatic Gastric Cancer: A Case Report.
251 ## - Source
Source Cureus. 8(1):e457, 2016 Jan 12.
252 ## - Abbreviated Source
Abbreviated source Cureus. 8(1):e457, 2016 Jan 12.
253 ## - Journal Name
Journal name Cureus
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Year 2016
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Manufacturer FY2016
265 ## - SOURCE FOR ACQUISITION/SUBSCRIPTION ADDRESS [OBSOLETE]
Publication status epublish
266 ## - Date added to catalog
Date added to catalog 2019-03-14
520 ## - SUMMARY, ETC.
Abstract Gastroesophageal adenocarcinomas represent one of the top five most common types of cancer worldwide. Despite significant advancement, it is still not known which first-line chemotherapy option is best matched to an individual patient. The vast advances in molecular biology have led to the discovery of many potential predictive biomarkers, such as HER-2 neu, thymidylate synthase (TS), excision repair cross-complementation group 1 (ERCC1), and topoisomerase-1 (TOPO1). These markers could allow us to select treatment based on an individual's tumor profile, resulting in an improvement of outcome. Our report highlights two patients with metastatic gastric cancer that achieved an exceptional response with traditional therapy and provides insights into the future perspectives of molecular profile-directed chemotherapy.
546 ## - LANGUAGE NOTE
Language note English
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element PubMed-not-MEDLINE -- Not indexed
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution MedStar Medical Group
651 ## - SUBJECT ADDED ENTRY--GEOGRAPHIC NAME
Institution Washington Cancer Institute
657 ## - INDEX TERM--FUNCTION
Medline publication type Case Reports
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Colton, Bradley
700 ## - ADDED ENTRY--PERSONAL NAME
Local Authors Manning, Maria A
790 ## - Authors
All authors Carroll JE, Colton B, Hartley M, Manning MA, Mikhail S, Salem ME, Smaglo BG, Xiu J
856 ## - ELECTRONIC LOCATION AND ACCESS
DOI <a href="https://dx.doi.org/10.7759/cureus.457">https://dx.doi.org/10.7759/cureus.457</a>
Public note https://dx.doi.org/10.7759/cureus.457
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type Journal Article
Item type description Article
Holdings
Withdrawn status Lost status Damaged status Not for loan Collection Home library Current library Date acquired Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
          MedStar Authors Catalog MedStar Authors Catalog 03/14/2019   26918225 26918225 03/14/2019 03/14/2019 Journal Article

Powered by Koha